policies >  DOI:10.25504/FAIRsharing.d8fvz
Did we miss something? Our COVID-19 Collection is growing, but not yet complete. Tell us what's missing. Email contact@fairsharing.org or add missing resources to our spreadsheet

ready Elsevier - Lancet Oncology - Information for Authors

General Information

Homepage https://www.thelancet.com/lanonc/about

Countries that developed this resource China , United Kingdom , United States

Published in 2000

Type: Journal


The Information for Authors page contains a broad range of guidelines for publishing in Lancet Oncology. With regards to data deposition, novel gene sequences should be deposited in a public database (GenBank, EMBL, or DDBJ), and the accession number provided. Authors of microarray papers should include in their submission the information recommended by the MIAME guidelines. Authors should also submit their experimental details to one of the publicly available databases: ArrayExpress or GEO.

Taxonomic range

How to cite this record FAIRsharing.org: Elsevier - Lancet Oncology - Information for Authors; DOI: https://doi.org/10.25504/FAIRsharing.d8fvz; Last edited: Feb. 18, 2020, 5:39 p.m.; Last accessed: Sep 22 2020 5:42 a.m.

This record is maintained by msoareses  ORCID

Record added: June 2, 2016, 11:16 a.m. Record updated: Feb. 18, 2020, 5:35 p.m. by The FAIRsharing Team.
Show edit history


Record Maintainer


Policy External Cross References

TOP Level Data Transparency: 0: Not TOP compliant

TOP qualifying comments: Data disclosure is required for clinical trials, but "For reports of research other than clinical trials, data sharing statements are encouraged but not required."

Usage / Access



Additional Information